Literature DB >> 26131082

Intermittent low-level vagosympathetic nerve trunk stimulation inhibits ganglionated plexi activity to prevent atrial fibrillation.

Yanmei Lu1, Juan Sun1, Ling Zhang1, Qingquan Sun1, Xianhui Zhou1, Jinxin Li1, Yu Zhang1, Baopeng Tang1.   

Abstract

BACKGROUND: The cardiac autonomic nervous system (CANS) plays a role in the occurrence and persistence of atrial fibrillation (AF). Low-level vagosympathetic nerve stimulation (LL-VNS) has been shown to inhibit the occurrence of AF.
OBJECTIVE: The novel objective of this study was to compare the effects of intermittent low- level vagosympathetic nerve stimulation (I-VNS) and continuous low-level vagosympathetic nerve stimulation (C-VNS).
METHODS: 19 beagles were randomly divided into 3 groups: Group A, rapid left atrial appendage pacing for 6 hours; Group B, rapid atrial pacing (RAP) for 6 hours and C-VNS (20 Hz, interval 0.1 ms, square wave) with 50% threshold voltage strength; Group C, RAP for 6 hours and I-VNS (continuously recurring cycles of 30-second ON, 30-second OFF). The atrial monophasic action potential (MAP) and the effective refractory periods (ERP) of the atrium and the pulmonary veins were measured at baseline, 1 hour, 3 hours and 6 hours after the experiment began. After the experiment, tyrosine hydroxylase (TH) and choline acetyl transferase (CHAT) expression levels in the anterior right ganglionated plexi (ARGP) from each group were measured.
RESULTS: Inter-group comparisons of MAP and ERP demonstrated that Group A was significantly different from Groups B and C (P < 0.05), while the difference between Groups B and C was not significant (P > 0.05). The MAP and ERP in Group A gradually decreased, reaching a minimum at 6 hours, but no significant changes were observed in Groups B and C. When compared to Group A, both Groups B and C had reduced TH and CHAT expression.
CONCLUSIONS: During the occurrence and development of AF, I-VNS could protect the cardiovascular system, possibly replacing C-VNS. Additionally, both I-VNS and C-VNS inhibited ganglionated plexus (GP) activity during the AF prevention.

Entities:  

Keywords:  Atrial fibrillation; ganglionated plexus; vagosympathetic nerve

Year:  2015        PMID: 26131082      PMCID: PMC4484029     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

Review 1.  Non-pharmacological modulation of the autonomic tone to treat heart failure.

Authors:  Jagmeet P Singh; Jagdesh Kandala; A John Camm
Journal:  Eur Heart J       Date:  2013-10-29       Impact factor: 29.983

Review 2.  Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications.

Authors:  Benjamin J Scherlag; Hiroshi Nakagawa; Warren M Jackman; Ralph Lazzara; Sunny S Po
Journal:  J Cardiovasc Transl Res       Date:  2010-11-06       Impact factor: 4.132

3.  Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle.

Authors:  Lilei Yu; Benjamin J Scherlag; Yong Sha; Shaolong Li; Tushar Sharma; Hiroshi Nakagawa; Warren M Jackman; Ralph Lazzara; Hong Jiang; Sunny S Po
Journal:  Heart Rhythm       Date:  2011-12-31       Impact factor: 6.343

Review 4.  Modern management of epilepsy: Vagus nerve stimulation.

Authors:  E Ben-Menachem
Journal:  Baillieres Clin Neurol       Date:  1996-12

5.  Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines.

Authors:  Mark J Shen; Tetsuji Shinohara; Hyung-Wook Park; Kyle Frick; Daniel S Ice; Eue-Keun Choi; Seongwook Han; Mitsunori Maruyama; Rahul Sharma; Changyu Shen; Michael C Fishbein; Lan S Chen; John C Lopshire; Douglas P Zipes; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Circulation       Date:  2011-05-09       Impact factor: 29.690

Review 6.  Animal models for atrial fibrillation: clinical insights and scientific opportunities.

Authors:  Kunihiro Nishida; Georghia Michael; Dobromir Dobrev; Stanley Nattel
Journal:  Europace       Date:  2009-10-29       Impact factor: 5.214

7.  Inhibition of atrial fibrillation by low-level vagus nerve stimulation: the role of the nitric oxide signaling pathway.

Authors:  Stavros Stavrakis; Benjamin J Scherlag; Youqi Fan; Yu Liu; Jun Mao; Vandana Varma; Ralph Lazzara; Sunny S Po
Journal:  J Interv Card Electrophysiol       Date:  2012-11-20       Impact factor: 1.900

Review 8.  Role of the autonomic nervous system in modulating cardiac arrhythmias.

Authors:  Mark J Shen; Douglas P Zipes
Journal:  Circ Res       Date:  2014-03-14       Impact factor: 17.367

Review 9.  Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.

Authors:  A Chambers; J M Bowen
Journal:  Ont Health Technol Assess Ser       Date:  2013-10-01

Review 10.  Role of neural modulation in the pathophysiology of atrial fibrillation.

Authors:  Shailesh Male; Benjamin J Scherlag
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

View more
  1 in total

1.  Clinical Effects of "Selective Drug" Regulating Vagus Nerve Signal Pathway in Vagally-Mediated Atrial Fibrillation.

Authors:  Xue Lou; Yanmei Lu; Baopeng Tang; Xianhui Zhou
Journal:  Med Sci Monit       Date:  2018-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.